HF
MRNA icon

HRT Financial’s Moderna MRNA Stock Holding History

HRT Financial’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-368,421
Closed -$19.1M – 4930
2026
Q1 		$18.7M Buy
+368,421
New +$17.2M 0.05% 357
2025
Q4 		– Sell
-531,782
Closed -$14.4M – 3711
2025
Q3 		$13.7M Buy
+531,782
New +$14.8M 0.05% 283
2025
Q1 		– Sell
-506,280
Closed -$18M – 3074
2024
Q4 		$21.1M Buy
+506,280
New +$24.2M 0.11% 119
2024
Q3 		– Sell
-54,376
Closed -$4.99M – 2865
2024
Q2 		$6.46M Buy
+54,376
New +$6.88M 0.04% 329
2023
Q3 		– Sell
-8,833
Closed -$985K – 2833
2023
Q2 		$1.07M Sell
8,833
-81,460
-90% -$10.9M 0.01% 912
2023
Q1 		$13.9M Buy
90,293
+87,201
+2,820% +$14.4M 0.17% 93
2022
Q4 		$555K Buy
+3,092
New +$506K 0.01% 1336
2022
Q1 		– Sell
-13,590
Closed -$2.29M – 3576
2021
Q4 		$3.45M Buy
+13,590
New +$3.97M 0.02% 410
2021
Q3 		– Sell
-596,019
Closed -$140M – 3591
2021
Q2 		$140M Buy
596,019
+582,300
+4,244% +$104M 1.28% 6
2021
Q1 		$1.8M Buy
+13,719
New +$1.99M 0.02% 680
2020
Q4 		– Sell
-14,497
Closed -$1.47M – 2230
2020
Q3 		$1.02M Buy
+14,497
New +$1.01M 0.03% 522

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

HRT Financial's MRNA Position: Q2 2026 in Review

HRT Financial sold out of Moderna (MRNA) in Q2 2026, closing a stake of 368,421 shares — an estimated $19.1M sold.

HRT Financial first reported a position in MRNA in Q3 2020 and held it in 11 quarters. The position peaked at $140M in Q2 2021. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • HRT Financial reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 368,421 Moderna shares in Q2 2026, an estimated $19.1M.
  • HRT Financial first reported a position in Moderna in Q3 2020 and held it in 11 quarters.
  • HRT Financial's Moderna position peaked at $140M in Q2 2021.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.